Cart
sales@molnova.com
Home - Products - Membrane Transporter/Ion Channel - Proton Pump - Abeprazan hydrochloride

Abeprazan hydrochloride

Abeprazan hydrochloride

Catalog No. M32767

Abeprazan hydrochloride (Fexuprazan hydrochloride) is an effective reversible potassium-competitive acid blocker with oral activity, inhibiting H+, K+ -atPase by competitive binding to potassium ions without acid activation.

Size Price / USD Stock Quantity
2MG 143 In Stock
5MG 226 In Stock
10MG 335 In Stock
25MG 522 In Stock
50MG 707 In Stock
100MG 888 In Stock
500MG 1782 In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Abeprazan hydrochloride
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Sunwoo J, et al. Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther. 2018 Jul;48(2):206-218.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Vonoprazan Fumarate

    Vonoprazan Fumurate, a novel potassium-competitive acid blocker, inhibits gastric acid secretion. Vonoprazan Fumurate inhibited H+,K+-ATPase activity in porcine gastric microsomes with IC50 value of 19 nM at pH 6.5.

  • Lansoprazole

    Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.

  • Revaprazan

    Revaprazan (SB-641257;YH-1885) is a potent potassium-competitive acid blocker (P-CAB) that inhibits H+,K+-ATPase in a reversible and K+-competitive manner.

Sign In Join Free